6 Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome

Amso, 1990, The management of predicted ovarian hyperstimulation involving gonadotrophin-releasing hormone analog with elective cryopreservation of all pre-embryos, Fertility and Sterility, 53, 1087, 10.1016/S0015-0282(16)53591-2 Andreyko, 1987, Therapeutic uses of gonadotrophin-releasing hormone analogs, Obstetrical and Gynecological Survey, 42, 1, 10.1097/00006254-198701000-00001 Asch, 1993, The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome, Human Reproduction, 8, 1015, 10.1093/oxfordjournals.humrep.a138185 Ashkenazi, 1990, Adverse neurological symptoms after gonadotrophin-releasing hormone analog therapy for in vitro fertilization cycles, Fertility and Sterility, 53, 738, 10.1016/S0015-0282(16)53475-X Awonuga, 1996, Outcome of frozen embryo replacement cycles following elective cryopreservation of all embryos in women at risk of ovarian hyperstimulation syndrome, Journal of Assisted Reproduction and Genetics, 13, 293, 10.1007/BF02070141 Awonuga, 1996, Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate, Journal of Assisted Reproduction and Genetics, 13, 401, 10.1007/BF02066172 Balen, 1993, Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by desensitization with buserelin, Human Reproduction, 8, 959, 10.1093/oxfordjournals.humrep.a138174 Barriere, 1987, Use of GnRH analogues in ovulation induction for in vitro fertilization: benefit of a short administration regimen, Journal of In Vitro Fertilization and Embryo Transfer, 4, 64, 10.1007/BF01555440 Battaglia, 1997, Color doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome, Gynecologic Endocrinology, 11, 105, 10.3109/09513599709152520 Belchetz, 1978, Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone, Science, 202, 631, 10.1126/science.100883 Biljan, 1997, The effect of administration of the oral contraceptive pill on the incidence of ovarian cyst formation during pituitary suppression Bramley, 1985, Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties, and luteal phase levels, Journal of Clinical Endocrinology and Metabolism, 61, 834, 10.1210/jcem-61-5-834 Buckett, 1998, Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose, Human Reproduction, 13, 811, 10.1093/humrep/13.4.811 Cahill, 1998, The risks of GnRH agonist administration in early pregnancy, 97 Chang, 1995, Unexpected pregnancies exposed to leuprolide acetate administered after the mid-luteal phase for ovarian stimulation, Human Reproduction, 10, 204, 10.1093/humrep/10.1.204 Clifford, 1994, An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases, Human Reproduction, 9, 1328, 10.1093/oxfordjournals.humrep.a138703 Clifford, 1996, Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial, British Medical Journal, 312, 1508, 10.1136/bmj.312.7045.1508 Daya, 1997, Optimal protocol for gonadotrophin releasing hormone agonist use in ovarian stimulation, 405 Derman, 1987, Regulation of pituitary response to gonadotrophin releasing hormone, vol 5, 1 Dirnfield, 1991, Randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response, Journal of In Vitro Fertilization and Embryo Transfer, 8, 339, 10.1007/BF01133025 Dodson, 1987, The effect of leuprolide acetate on ovulation induction with HMG in PCOS, Journal of Clinical Endocrinology and Metabolism, 65, 95, 10.1210/jcem-65-1-95 Engmann L, Maconochie N, Bekir JS et al (submitted) Multiple cycle package improves the ultimate prospects of success in an in vitro fertilization programme. British Journal of Obstetrics and Gynaecology. Farhi, 1993, The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene, Human Reproduction, 8, 1367, 10.1093/oxfordjournals.humrep.a138262 Filicori, 1994, Treatment of anovulation with pulsatile gonadotrophin-releasing hormone: prognostic factors and clinical results in 600 cycles, Journal of Clinical Endocrinology and Metabolism, 79, 1215, 10.1210/jc.79.4.1215 Filicori, 1998, Use of pulsatile gonadotrophin-releasing hormone to induce monofolliculogenesis in polycystic ovary syndrome, 55 Forman, 1990, Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in-vitro fertilization: a European series and a proposal for prevention, Fertility and Sterility, 53, 502, 10.1016/S0015-0282(16)53348-2 Frydman, 1988, Comparison between flare up and down regulation effects of luteinizing hormone releasing hormone agonists in an in vitro fertilization program, Fertility and Sterility, 50, 471, 10.1016/S0015-0282(16)60135-8 Furr, 1987, Pharmacological studies with Zoladex, a novel LHRH analogue, 1 Gerhard, 1993, The induction of ovulation with pulsatile gonadotrophin releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive, Human Reproduction, 8, 2033, 10.1093/oxfordjournals.humrep.a137977 Gerris, 1995, Triggering of ovulation in human menopausal gonadotrophin stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 μg), GnRH agonist (buserelin, 500μg) and human chorionic gonadotrophin (10000 IU), Human Reproduction, 10, 56, 10.1093/humrep/10.1.56 Gonen, 1993, Outcome of pregnancies inadvertently exposed to gonadotrophin-releasing hormone analogues (GnRH-a) in early gestation, Journal of Assisted Reproduction and Genetics, 10, 437, 10.1007/BF01228095 Hodgen, 1990, Uses of GnRH analogues in IVF/GIFT, Contemporary Obstetrics and Gynecology, 35, 10 Hull, 1987, Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies, Gynecologic Endocrinology, 1, 235, 10.3109/09513598709023610 Insler, 1990, The combined pituitary suppression/ovarian stimulation therapy: myths and realities, 31 Jeffcoate, 1974, Blood and urine clearance of luteinizing hormone releasing hormone in man measured by radioimmunoassay, Journal of Endocrinology, 60, 305, 10.1677/joe.0.0600305 Kang, 1989, Effect of treatment with gonadotrophin-releasing hormone analogues on pregnancy outcome in the baboon, Fertility and Sterility, 52, 846, 10.1016/S0015-0282(16)53051-9 Knobil, 1980, The neuroendocrine control of the menstrual cycle, Recent Progress in Hormone Research, 36, 53 Lanzone, 1989, LH surge induction by GnRH agonist at the time of ovulation, Gynecologic Endocrinology, 3, 213, 10.3109/09513598909152302 MacDougall, 1993, In vitro fertilisation and the ovarian hyperstimulation syndrome, Human Reproduction, 7, 597, 10.1093/oxfordjournals.humrep.a137702 MacDougall, 1992, A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization, Human Reproduction, 8, 233, 10.1093/oxfordjournals.humrep.a138029 Macnamee, 1989, Short term luteinizing hormone releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization, Fertility and Sterility, 52, 264, 10.1016/S0015-0282(16)60853-1 Macrow, 1994, Endometrial structure after superovulation: a prospective controlled study, Fertility and Sterility, 61, 696, 10.1016/S0015-0282(16)56647-3 Martin, 1993, Comparison of exogenous gonadotrophins and pulsatile gonadotrophin releasing hormone for induction of ovulation in hypogonadotrophic amenorrhea, Journal of Clinical Endocrinology and Metabolism, 77, 125, 10.1210/jc.77.1.125 Matta, 1988, Endocrinologic and clinical evaluation following a single administration of a gonadotrophin releasing hormone agonist (Zoladex) in a depot formulation to premenopausal women, Fertility and Sterility, 49, 163, 10.1016/S0015-0282(16)59670-8 van der Meer, 1993, Triggering of ovulation using gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome, Human Reproduction, 8, 1628, 10.1093/oxfordjournals.humrep.a137903 Miyachi, 1973, Metabolism of 125I-luteinizing hormone releasing hormone, Journal of Clinical Endocrinology and Metabolism, 37, 63, 10.1210/jcem-37-1-63 Naor, 1980, Calcium dependent actions of GnRH on pituitary 3′,5′c-GMP production and gonadotrophin release, Endocrinology, 107, 1438, 10.1210/endo-107-5-1438 Neveu, 1987, Ovarian stimulation by a combination of gonadotrophin releasing hormone agonist and gonadotrophins for in vitro fertilization, Fertility and Sterility, 47, 639, 10.1016/S0015-0282(16)59115-8 Pellicer, 1992, The use of gonadotrophin-releasing hormone analogues (GnRH-a) in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary, Human Reproduction, 7, 39, 10.1093/humrep/7.suppl_1.39 Porter, 1984, Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins, Lancet, ii, 1284, 10.1016/S0140-6736(84)92840-X Rajfer, 1986, Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer, Fertility and Sterility, 46, 104, 10.1016/S0015-0282(16)49466-5 Rizk, 1991, Modern management of ovarian hyperstimulation syndrome, Human Reproduction, 6, 1082, 10.1093/oxfordjournals.humrep.a137488 Ron-El, 1990, The comparison of early follicular and midluteal administration of long-acting gonadotrophin releasing hormone agonist, Fertility and Sterility, 54, 233, 10.1016/S0015-0282(16)53695-4 San Roman, 1992, A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotrophin-releasing hormone agonist for in vitro fertilization, Fertility and Sterility, 58, 744, 10.1016/S0015-0282(16)55322-9 Sandow, 1987, Clinical pharmacokinetics of LHRH analogues, 1 Sandow, 1987, Buserelin: pharmocokinetics, metabolism and mechanisms of action, British Journal of Clinical Practice, 41, S6 Scheele, 1993, Pulsatile gonadotrophin-releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome, Human Reproduction, 8, 197, 10.1093/humrep/8.suppl_2.197 Schoot, 1992, Effects of gonadotrophin releasing hormone agonist addition to gonadotrophin induction of ovulation in polycystic ovary syndrome patients, European Journal of Obstetrics and Gynecology and Reproductive Biology, 45, 53, 10.1016/0028-2243(92)90193-3 Schwartz, 1981, The use of gonadotrophins for induction of ovulation, Fertility and Sterility, 35, 3, 10.1016/S0015-0282(16)45249-0 Shaker, 1995, Administration of progestogens to hasten pituitary desensitization after the use of gonadotrophin releasing hormone agonist in in vitro fertilization—a prospective randomized study, Fertility and Sterility, 64, 791, 10.1016/S0015-0282(16)57856-X Shaker, 1996, Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome, Fertility and Sterility, 65, 992, 10.1016/S0015-0282(16)58275-2 Stein, 1935, Amenorrhea associated with bilateral polycystic ovary syndrome, American Journal of Obstetrics and Gynecology, 29, 181, 10.1016/S0002-9378(15)30642-6 Stephenson, 1991, The risks associated with ovulation induction, Iatrogenics, 1, 7 Steptoe, 1970, Laparoscopic recovery of pre-ovulatory human oocytes after priming of ovaries with gonadotrophins, Lancet, i, 683, 10.1016/S0140-6736(70)90923-2 Surrey, 1989, Effects of gonadotrophin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease, Fertility and Sterility, 52, 547, 10.1016/S0015-0282(16)60961-5 Takahashi, 1995, Transvaginal ultrasound morphology in polycystic ovarian syndrome, Gynecology and Obstetric Investigation, 39, 201, 10.1159/000292409 Tan, 1994, Simplifying in vitro fertilization therapy, Current Opinion in Obstetrics and Gynecology, 6, 111, 10.1097/00001703-199404000-00001 Tan, 1996, Gonadotrophin-releasing hormone agonists in ovulation induction, 403 Tan, 1992, A prospective randomised study of the optimum timing of human chorionic gonadotrophin administration after pituitary desensitization in in vitro fertilization, Fertility and Sterility, 57, 1259, 10.1016/S0015-0282(16)55084-5 Tan, 1992, The long protocol of administration of gonadotrophin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization, Fertility and Sterility, 57, 810, 10.1016/S0015-0282(16)54963-2 Tan, 1992, A prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery, Fertility and Sterility, 58, 356, 10.1016/S0015-0282(16)55230-3 Tan, 1994, Cumulative conception and live birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotrophin-releasing hormone agonist buserelin, American Journal of Obstetrics and Gynecology, 171, 513, 10.1016/0002-9378(94)90291-7 Tan, 1996, Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH, Obstetrics and Gynecology, 88, 221, 10.1016/0029-7844(96)00190-1 Tan, 1996, The role of gonadotrophin-releasing hormone and its agonists in infertility, 537 Wada, 1993, Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome, British Journal of Obstetrics and Gynaecology, 100, 365, 10.1111/j.1471-0528.1993.tb12981.x Werlin, 1983, Gonadotrophin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized intermittent regimen, Journal of Clinical Endocrinology and Metabolism, 56, 844, 10.1210/jcem-56-4-844 Zaidi, 1995, Ovarian stromal blood flow in women with polycystic ovaries—a possible new marker for diagnosis?, Human Reproduction, 10, 1992, 10.1093/oxfordjournals.humrep.a136222